Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea

This study is testing whether semaglutide, a medication used for weight loss and diabetes, can also improve sleep apnea in people who have both type 2 diabetes or obesity and obstructive sleep apnea (a condition where breathing repeatedly stops during sleep). **You may be eligible if...** - You are 18 to 65 years old - Your BMI is 27 or higher, and you have at least one of: high blood pressure, high cholesterol, cardiovascular disease, or type 2 diabetes - Diet and exercise alone have not been enough to manage your condition - You have been diagnosed with obstructive sleep apnea - You have complete medical records available **You may NOT be eligible if...** - Your weight gain is caused by a hormonal disorder (like Cushing's syndrome or an underactive thyroid) - You have severe kidney or liver problems - You received hormonal drugs, antibiotics, or weight-loss surgery in the past month Talk to your doctor to see if this trial is right for you.